Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 19;10(12):e33238.
doi: 10.1016/j.heliyon.2024.e33238. eCollection 2024 Jun 30.

Development of an aptasensor for highly sensitive detection of cardiac troponin I using cobalt-nickel metal-organic framework (CoNi-MOF)

Affiliations

Development of an aptasensor for highly sensitive detection of cardiac troponin I using cobalt-nickel metal-organic framework (CoNi-MOF)

Ramya Devaraj et al. Heliyon. .

Abstract

Objective and rationale: This study aimed to develop a highly sensitive and selective single-stranded DNA (ssDNA) aptamer targeting cardiac troponin I (cTnI), a crucial biomarker for acute myocardial infarction (AMI). The objective was to fabricate a novel aptamer electrochemical sensor using a composite material of cobalt-nickel metal-organic framework (CoNi-MOF) on screen-printed carbon electrodes (SPCE), leveraging the composite's large surface area and excellent electrical conductivity alongside the aptamer's high affinity for cTnI.

Methods: The aptamer electrochemical sensor was fabricated using the CoNi-MOF composite on SPCE and characterized its properties. They conducted electrochemical measurements to assess the sensor's performance in detecting cTnI. The sensor's stability, reproducibility, and electro-catalytic activity were evaluated.

Results: The sensor demonstrated linear detection of cTnI over a concentration range of 5-75 pg/mL, with a low limit of detection (LOD) of 13.2 pM. Remarkable stability and reproducibility were observed in cTnI detection. The sensor exhibited exceptional electro-catalytic activity, enabling accurate quantification of cTnI levels in various solutions.

Conclusions: This research presents a significant advancement towards the development of reliable, cost-effective, and easily deployable cTnI sensors for clinical applications. The sensor's versatility in detecting cTnI across different concentration ranges highlights its potential utility in diverse clinical settings, particularly for early detection and monitoring of cardiac conditions.

Keywords: Aptamer; Cardiac troponin; Diagnostic sensor; Electrochemical; Metal-organic framework.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: AshokKumar Loganathan reports financial support was provided by 10.13039/501100001411Indian Council of Medical Research. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Scheme 1
Scheme 1
Schematic representation of aptamer based electrochemical detection of Cardiac Troponin-I.
Fig. 1
Fig. 1
XRD pattern for CoNi-MOF.
Fig. 2
Fig. 2
Raman spectra of CoNi-MOF.
Fig. 3
Fig. 3
FT-IR Spectra profile of CoNi-MOF.
Fig. 4
Fig. 4
(a–b) FE-SEM image of CoNi-MOF, (c–h) colour mapping results of CoNi-MOF, (c) mixed colour mapping, (d–h) mapping results of C, N, O, Ni and Co respectively.
Fig. 5
Fig. 5
CV of Bare SPCE, CoNi-MOF/SPCE and AcTnI/CoNi-MOF/SPCE in 50 mV/s Scan rate.
Fig. 6
Fig. 6
EIS characterisation of bare SPCE(black), CoNi-MOF/SPCE(red), AcTnI/CoNi-MOF/SPCE(green).
Fig. 7
Fig. 7
The role of (a) AcTnI concentration and (b) incubation duration on sensing efficiency.
Fig. 8
Fig. 8
a) DPV curves of AcTnI/CoNi-MOF/SPCE in relation to 5 pg/ml, 10 pg/ml, 15 pg/ml, 25 pg/ml, 50 pg/ml, and 75 pg/ml (b) Linear correlation between current and logarithm of cTnI concentrations.
Fig. 9
Fig. 9
Selectivity evaluation of the sensor.

Similar articles

Cited by

References

    1. Cesare M.D., Bixby H., Gaziano T., Hadeed L., Kabudula C., McGhie D.V., Mwangi J., Pervan B., Perel P., Piñeiro D., Taylor S., Pinto F. 2023. World Heart Report 2023: Confronting the World's Number One Killer; pp. 1–52.
    1. Tveit S.H., Myhre P.L., Hanssen T.A., Forsdahl S.H., Iqbal A., Omland T., Schirmer H. Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome. Sci. Rep. 2022;12:1–9. doi: 10.1038/s41598-022-04850-7. - DOI - PMC - PubMed
    1. Senf B., Yeo W.H., Kim J.H. Recent advances in portable biosensors for biomarker detection in body fluids. Biosensors. 2020;10 doi: 10.3390/BIOS10090127. - DOI - PMC - PubMed
    1. Pohanka M., Skládal P. Electrochemical biosensors - principles and applications. J. Appl. Biomed. 2008;6:57–64. doi: 10.32725/jab.2008.008. - DOI
    1. Sumitha M.S., Xavier T.S. Recent advances in electrochemical biosensors – a brief review. Hybrid Adv. 2023;2 doi: 10.1016/j.hybadv.2023.100023. - DOI

LinkOut - more resources